Vratislav Strnad

Phase III Randomized Trial of Amifostine as a Radioprotector in Head and Neck Cancer

David M. Brizel, Todd H. Wasserman, Michael Henke et al. · Journal of Clinical Oncology · 2000 · 832 citations

Medicine, Oncology, Radiation Oncology +15

5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial

Vratislav Strnad, Oliver J. Ott, Guido Hildebrandt et al. · The Lancet · 2015 · 656 citations

Medicine, Oncology, Radiation Oncology +16

Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009)

Csaba Polgár, Erik Van Limbergen, Richard Pötter et al. · Radiotherapy and Oncology · 2010 · 633 citations

Medicine, Oncology, Radiation Oncology +17

Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial

Csaba Polgár, Oliver J. Ott, Guido Hildebrandt et al. · The Lancet Oncology · 2017 · 255 citations

Medicine, Oncology, Radiation Oncology +17

Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and- neck cancer: 2-year follow-up of a prospective, randomized, phase III trial

Todd H. Wasserman, David M. Brizel, Michael Henke et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 170 citations

Medicine, Oncology, Radiation Oncology +13